Table 4

Description of hypercoagulopathic complications (confirmed DVT and catheter thrombosis (≥3 episodes), stroke, and use of therapeutic anticoagulation)

Patient numberDVTDVT locationClotted central venous cathetersConfirmed strokeTherapeutic anticoagulationAnticoagulation use (days)HDComorbidities
1YY4YMG
2HLD, HTN
3YY24HTN, DM
4Y6None
5HTN, TIA
6YHTN
7YBrachial veinYY6None
8Y2CP
9Y3DA
10CILI
11YInternal jugularY7HTN, EtOH
12Y23YHLD, PVD, SZ
13Y3YHTN, CHF
14HTN
15Y9YHTN, DM, MG
16CILI, EtOH
17YY14ARF, HTN, DM
18Y15HTN, DM, TIA
19Y11YHTN, DM
20Y6HLD, CHF, HTN, COPD, CAD
21YY2YHLD, HTN, DM
  • CAD, coronary artery disease; CHF, congestive heart failure; CILI, cirrhosis of the liver; COPD, chronic obstructive pulmonary disease; CP, cerebral palsy; DA, drug abuse; DM, diabetes; DVT, deep vein thrombosis; EtOH, alcohol use; HD, hemodialysis; HLD, hyperlipidemia; HTN, hypertension; MG, myasthenia gravis; PVD, peripheral vascular disease; SZ, seizure; TIA, transient ischemic attack; Y, yes.